Author:
Al-Ahmadie Hikmat A.,Alden Darym,Qin Li-Xuan,Olgac Semra,Fine Samson W.,Gopalan Anuradha,Russo Paul,Motzer Robert J.,Reuter Victor E.,Tickoo Satish K.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pathology and Forensic Medicine,Surgery,Anatomy
Reference40 articles.
1. Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer;Atkins;Clin Cancer Res,2005
2. A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients;Bleumer;Br J Cancer,2004
3. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy;Bui;Clin Cancer Res,2003
4. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma;Chia;J Clin Oncol,2001
5. Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma;Divgi;Clin Cancer Res,1998
Cited by
86 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献